IP Library Granted Patent US 12,539,402
Granted Patent B2
US 12,539,402 · App. 18/465,531 · Granted Feb 3, 2026

Micro-needle bladder balloon

Inventors: Carrie Lee Herman (Minnetonka, MN); Natalie Ann Borgos (Roseville, MN); Kari L. Cierzan (Minnetonka, MN)
Assignee: Boston Scientific Scimed, Inc.
A61M25/10A61M31/00A61M37/0015A61M2025/1013A61M2025/105A61M2025/1086A61M2037/0023A61M2037/003A61M2037/0046A61M2037/0061
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,539,402
App. No.
18/465,531
Granted
Feb 3, 2026
Kind
B2
Abstract

Devices and methods for delivering treatment fluids or particulates such as, stem cells, drugs, Botox and like, to an inner lining of a bladder for treatment of urinary tract disorders, including over-active bladder. A balloon delivery system can include an inflation balloon having a plurality of micro-needles configured to pierce and otherwise puncture an inner bladder wall so as to deliver the treatment fluid to bladder tissue. The treatment fluid can be directly injected into the bladder tissue using the micro needles. Alternatively, the micro needles can be fabricated of bioabsorbable or bioresorbable materials such that the micro needles can remain embedded within the bladder tissue to deliver the treatment fluid or particulate.

Claims (12)

1 . A balloon delivery system for delivering a treatment fluid to bladder tissue, comprising:

a balloon catheter including a catheter body having a distal treatment end, the distal treatment end including an inflation balloon and an internal balloon,

the internal balloon having an external surface defining a plurality of lowered portions,

the inflation balloon includes a plurality of micro needles, each micro needle including a needle tip for puncturing an inner bladder wall for delivery of a treatment medicant into bladder tissue, each micro needle being associated with at least one of the plurality of lowered portions of the external surface of the internal balloon, a first portion of the inflation balloon being disposed a first distance from the internal balloon, a second portion of the inflation balloon being disposed a second distance from one of the plurality of lowered portions of the internal balloon, the second distance being greater than the first distance.

2 . The balloon delivery system of claim 1 , wherein the plurality of micro needles are formed directly on an exterior surface of the inflation balloon.

3 . The balloon delivery system of claim 2 , wherein a treatment fluid is located between the inflation balloon and the internal balloon such that inflation of the internal balloon pressurizes the treatment fluid for injection through the plurality of micro needles.

4 . The balloon delivery system of claim 3 , wherein each micro needle is defined within a recessed area on the exterior surface, the recessed area further comprising a pair of hinges with a hinge on each side of the micro needle, wherein inflation of the internal balloon causes each recessed area to be directed outward with the pair of hinges directing each micro needle into the inner bladder wall.

5 . The balloon delivery system of claim 3 , wherein each micro needle comprises a stiff dimple formed by passing a needle through an interior surface of inflation balloon and out the exterior surface such that said stiff dimple punctures the inner bladder wall with the inflation balloon in the fully inflated disposition.

6 . The balloon delivery system of claim 2 , wherein each micro needle is fabricated of a bioabsorbable or bioresorbable polymer and wherein each micro needle comprises a plurality of barbs such that each barb becomes embedded in the inner bladder wall with the inflation balloon in a fully inflated disposition and whereupon said plurality of barbs retain each micro needle within the inner bladder wall as the inflation balloon is deflated and assumes an uninflated disposition causing each micro needle to break off of the exterior surface of the inflation balloon.

7 . The balloon delivery system of claim 6 , wherein a treatment medicant is administered into bladder tissue during a time period in which the bioabsorbable or bioresorbable polymer is broken down by the bladder tissue.

8 . The balloon delivery system of claim 7 , wherein each micro needle includes an internal reservoir for retaining the treatment medicant.

9 . The balloon delivery system of claim 7 , wherein the treatment medicant is included within the bioabsorbable or bioresorbable polymer during formation of each micro needle.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2023
From: HERMAN, CARRIE LEE; BORGOS, NATALIE ANN; CIERZAN, KARI L
To: AMS RESEARCH CORPORATION
Reel/Frame 064877/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2023
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 064880/0464 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2023
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 064880/0584 →
CHANGE OF NAME Recorded Sep 12, 2023
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 064880/0658 →
CHANGE OF NAME Recorded Sep 12, 2023
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 064880/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2023
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 065563/0335 →
Continuity (4)
Continuation 16783600 · Feb 6, 2020
Continuation 13993752
Provisional Application 61423732 · Dec 16, 2010
Related Publication 20230414906A1 · Dec 28, 2023
References Cited (88)
US 2819718A · Goldman et al. · 1958 [cited by applicant]
US 2936760A · Gants · 1960 [cited by applicant]
US 4261339A · Hanson et al. · 1981 [cited by applicant]
US 4444188A · Bazell et al. · 1984 [cited by applicant]
US 4456011A · Warnecke · 1984 [cited by applicant]
US 4573966A · Weikl et al. · 1986 [cited by applicant]
US 4610662A · Weikl et al. · 1986 [cited by applicant]
US 4636195A · Wolinsky · 1987 [cited by applicant]
US 4637396A · Cook · 1987 [cited by applicant]
US 4660560A · Klein · 1987 [cited by applicant]
US 4702252A · Brooks et al. · 1987 [cited by applicant]
US 4705502A · Patel · 1987 [cited by applicant]
US 4781677A · Wilcox · 1988 [cited by applicant]
US 4932956A · Reddy et al. · 1990 [cited by applicant]
US 4932958A · Reddy et al. · 1990 [cited by applicant]
US 5188595A · Jacobi · 1993 [cited by applicant]
US 5312456A · Reed et al. · 1994 [cited by applicant]
US 5344397A · Heaven et al. · 1994 [cited by applicant]
US 5421826A · Crocker et al. · 1995 [cited by applicant]
US 5549555A · Sohn · 1996 [cited by applicant]
US 5707357A · Mikhail et al. · 1998 [cited by applicant]
US 5810767A · Klein · 1998 [cited by examiner]
US 5868776A · Wright · 1999 [cited by applicant]
US 6083166A · Holdaway et al. · 2000 [cited by applicant]
US 6283947B1 · Mirzaee · 2001 [cited by applicant]
US 6364855B1 · Zappala · 2002 [cited by applicant]
US 6471672B1 · Brown et al. · 2002 [cited by applicant]
US 6529011B1 · Okubo · 2003 [cited by applicant]
US 6638246B1 · Naimark · 2003 [cited by examiner]
US 6719709B2 · Whalen et al. · 2004 [cited by applicant]
US 6743211B1 · Prausnitz et al. · 2004 [cited by applicant]
US 6863654B2 · Zappala et al. · 2005 [cited by applicant]
US 7001405B2 · Kieturakis et al. · 2006 [cited by applicant]
US 7220252B2 · Shah · 2007 [cited by applicant]
US 7338468B2 · Freyman · 2008 [cited by examiner]
US 10589070B2 · Herman et al. · 2020 [cited by applicant]
US 11357955B2 · Herman et al. · 2022 [cited by applicant]
US 20020173745A1 · Santini et al. · 2002 [cited by applicant]
US 20030153905A1 · Edwards · 2003 [cited by examiner]
US 20040087995A1 · Copa et al. · 2004 [cited by applicant]
US 20040226556A1 · Deem et al. · 2004 [cited by applicant]
US 20050070938A1 · Copa et al. · 2005 [cited by applicant]
US 20050131269A1 · Talmadge · 2005 [cited by applicant]
US 20050131431A1 · Copa et al. · 2005 [cited by applicant]
US 20060058815A1 · Mickley et al. · 2006 [cited by applicant]
US 20060079836A1 · Holman et al. · 2006 [cited by applicant]
US 20060206122A1 · Copa et al. · 2006 [cited by applicant]
US 20060217680A1 · Barath · 2006 [cited by applicant]
US 20060264985A1 · Copa et al. · 2006 [cited by applicant]
US 20060276811A1 · Copa et al. · 2006 [cited by applicant]
US 20070191766A1 · McMorrow · 2007 [cited by applicant]
US 20070219584A1 · Copa et al. · 2007 [cited by applicant]
US 20080051723A1 · Laermer et al. · 2008 [cited by applicant]
US 20080108959A1 · Jung et al. · 2008 [cited by applicant]
US 20090187167A1 · Sexton · 2009 [cited by examiner]
US 20090227949A1 · Knapp et al. · 2009 [cited by applicant]
US 20090240199A1 · Rahimsobhani et al. · 2009 [cited by applicant]
US 20090254064A1 · Boatman · 2009 [cited by applicant]
US 20100076401A1 · Von Oepen · 2010 [cited by examiner]
US 20110166516A1 · Orr · 2011 [cited by examiner]
US 20120041412A1 · Roth et al. · 2012 [cited by applicant]
US 20120220981A1 · Soo et al. · 2012 [cited by applicant]
US 20130331783A1 · Herman et al. · 2013 [cited by applicant]
EP 0363203A2 · 1990 [cited by applicant]
EP 0444831A2 · 1991 [cited by applicant]
EP 0547358A3 · 1993 [cited by applicant]
EP 1031328A1 · 2000 [cited by applicant]
EP 1844736A1 · 2007 [cited by applicant]
WO 9626748A2 · 1996 [cited by applicant]
WO 2004034913A1 · 2004 [cited by applicant]
WO 2006102573A1 · 2006 [cited by applicant]
WO 2010024871A1 · 2010 [cited by applicant]
WO 2010065030A1 · 2010 [cited by applicant]
Acconcia, et al, “Sutureless' Vesicourethral Anastomosis in Radical Retropubic Prostatectomy”, The American Journal of Urology Review, Mar./Apr. 2003, vol. 1, No. 2, pp. 93-96. [cited by applicant]
Chancellor, at al, “Intraoperative Endo-Luminal Ultrasound Evaluation of Urethral Diverticula”, The Journal of Urology, vol. 153, Jan 1895, pp. 72-75. [cited by applicant]
Communication pursuant to Rule 71(3) EPC for European Application No. 11848939.2, mailed Jun. 26, 2018, 31 pages. [cited by applicant]
Crook, et al, “Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation”, Int. J. Radiation Oncology Biol. Phys., vol. 52, No. 2, 2002, pp. 453-460. [cited by applicant]
Diederich, et al, “Catheter-based ultrasound applicators for selective thermal ablation: progress towards MRI-guided applications in prostate”, Int. J. Hyperthermia, vol. 20, No. 7, Nov. 2004, pp. 739-756. [cited by applicant]
Extended European Search Report for European Application No. 11848939.2, mailed Aug. 10, 2017, 10 pages. [cited by applicant]
First Examiner's Report for Australian Application No. 2016203384, mailed Jun. 1, 2018, 5 pages. [cited by applicant]
Igel, et al, “Comparison of Techniques for Vesicourethral Anastomosis: Simple Direct Versus Modified Vest Traction Sutures”, Urology, vol. 31, No. 6, Jun. 1988, pp. 474-477. [cited by applicant]
Lee, et al, “Dosimetric Consequences of Using a Surrogate Urethra to Estimate Urethral Dose After Brachytherapy for Prostate Cancer”, Int. J. Radiation Oncology Biol. Phys., vol. 57, No. 2, 2003, pp. 355-361. [cited by applicant]
Merrick, et al, “Phophylactic Versus Therapeutic Alpha-Blockers After Permanent Prostate Brachytherapy”, Urology 60 (4), 2002, pp. 650-655. [cited by applicant]
Ross, et al, “Highly Directional Transurethral Ultrasound Applicators with Rotational Control for MRI-Guided Prostatic Thermal Therapy”, Phys. Med. Biol. 49, 2004, pp. 189-204. [cited by applicant]
Ryu, et al, “MRI Imaging of the Male and Female Urethra”, Radiographics, Sep.-Oct. 2001, pp. 1169-1185. [cited by applicant]
Vaidyanathan, et al, “A Simple Radiological Technique for Demonstration of Incorrect Positioning of a Foley Catheter with Balloon Inflated in the Urethra of a Male Spinal Cord Injury Patient”, Scientific Word Journal, J… [cited by applicant]
Zlotta, et al, “Percutaneous Transperineal Radiofrequency Ablation of Prostate Tumor: Safety, Feasibility and Pathological Effects on Human Prostate Cancer”, British Journal of Urology, vol. 81, Feb. 1998, pp. 265-275. [cited by applicant]
Zelefsky , “Postimplantation Dosimetric Analysis of Permanent Transperineal Prostate Implantation: Improved Does Distributions with an Intraoperative Computer-Optimized Conformal Planning Technique”, Int. J. Radiation O… [cited by applicant]